title: Oncogene-dependent engraftment of human myeloid leukemia cells in immunosuppressed mice.
abstract: We have developed an in vivo model of differentiated human acute myeloid leukemia (AML) by retroviral infection of the cytokine-dependent AML cell line TF-1 with the v-Src oncogene. When injected either intravenously or intraperitoneally into 300 cGy irradiated SCID mice, animals formed multiple granulocytic sarcomas involving the adrenals, kidneys, lymph nodes and other organs. The mean survival time was 34+/-10 days (n = 40) after intravenous injection and 24+/-3 days (n = 5) after intraperitoneal injection of 20 million cells. The cells recovered from leukemic animals continued to express interleukin-3 receptors and remained sensitive to the diphtheria fusion protein DT388IL3. Further, these granulocytic sarcoma-derived cells grew again in irradiated SCID mice (n = 10). The cytogenetic abnormalities observed prior to inoculation in mice were stably present after in vivo passage. Similar to the results with v-Src transfected TF-1 cells, in vivo leukemic growth was observed with TF-1 cells transfected with the human granulocyte-macrophage colony-stimulating factor gene (n = 5) and with TF-1 cells recovered from subcutaneous tumors in nude mice (n = 5). In contrast, TF-1 cells expressing v-Ha-Ras (n = 5), BCR-ABL (n = 5), or activated Raf-1 (n = 44) did not grow in irradiated SCID mice. This is a unique, reproducible model for in vivo growth of a differentiated human acute myeloid leukemia and may be useful in the assessment of anti-leukemic therapeutics which have human-specific molecular targets such as the interleukin-3 receptor.
authors.affiliation: Department of Cancer Biology, Pediatrics and Pathology, Wake Forest University School of Medicine, Winston-Salem, NC 27157, USA.
authors.forename: M
authors.initials: M
authors.lastname: Kiser
authors.forename: J A
authors.initials: JA
authors.lastname: McCubrey
authors.forename: L S
authors.initials: LS
authors.lastname: Steelman
authors.forename: J G
authors.initials: JG
authors.lastname: Shelton
authors.forename: J
authors.initials: J
authors.lastname: Ramage
authors.forename: R L
authors.initials: RL
authors.lastname: Alexander
authors.forename: G L
authors.initials: GL
authors.lastname: Kucera
authors.forename: M
authors.initials: M
authors.lastname: Pettenati
authors.forename: M C
authors.initials: MC
authors.lastname: Willingham
authors.forename: M S
authors.initials: MS
authors.lastname: Miller
authors.forename: A E
authors.initials: AE
authors.lastname: Frankel
mesh_terms: D000818:Animals; D002869:Chromosome Aberrations; D005260:Female; D016391:Genes, src / Q000502:physiology*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000502:physiology; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000235:genetics / Q000473:pathology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D016513:Mice, SCID; D016185:Receptors, Interleukin-3 / Q000032:analysis; D014407:Tumor Cells, Cultured
chemical_list: D016185:Receptors, Interleukin-3; D016178:Granulocyte-Macrophage Colony-Stimulating Factor